InvestorsHub Logo
Followers 740
Posts 61502
Boards Moderated 10
Alias Born 10/05/2009

Re: BIOCHEMUP post# 27582

Sunday, 10/17/2021 12:13:00 PM

Sunday, October 17, 2021 12:13:00 PM

Post# of 29737
I disagree. If a company is making progress they should fund growth with profits and when and if needed, fund growth or R&D with selling new shares at higher prices and build value. That rewards companies for doing something more than paying CEO's $500,000/year to golf and waste company money on BS, while they print BS PRs.

Toxic loans are a death sentence for companies and shareholder value.
Today's toxic loan methods were felonies called loan sharking in my younger years.

The loan sharks use shady brokers to short and distort stock prices down 90%, then print 9 times as many shares, then force CEOs to PR pump BS to rally the stock 1000% so the loan sharks can make 100,000% profits on these toxic loans.

The Fact the US Gov agencies allow this makes them complicity.

If the debt is convertible it should be at fixed price.

If $PMPG has something real, they should be able to raise cash at a fixed share price, not with loan shark toxic debt. Especially with share prices already being 85% of the 52 week high.

Toxic loan shark debt is like leaving the back door of Fort Knox open and tweeting the fact the gold is there to steal with the guards on vacation.

When I started my company, pre IPO, I funded it out of my own pocket, then I brought in real investors and they bought shares at $2.00/share. I never ever sold new shares for less than $2.00/share

...........

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMPG News